Shin Nippon Biomedical Laboratories (TSE:2395) Cyclically Adjusted Book per Share: 円676.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2395 Shin Nippon Biomedical Laboratories Ltd TSE:2395
74 GF Score
Price 円1,279.00
GF Value 円1,783.15
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share?

Shin Nippon Biomedical Laboratories TSE:2395 -1.99% 74 Cyclically Adjusted Book per Share is 円676.11 as of Mar. 2026. GuruFocus rates TSE:2395 with a GF Score™ of 74/100 and a GF Value™ of 円1,783.15 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was 円1,035.760. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円676.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shin Nippon Biomedical Laboratories's average Cyclically Adjusted Book Growth Rate was 11.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 13.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shin Nippon Biomedical Laboratories was 15.30% per year. The lowest was 5.40% per year. And the median was 10.85% per year.

As of today (2026-07-20), Shin Nippon Biomedical Laboratories's current stock price is 円1279.00. Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円676.11. Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio of today is 1.89.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shin Nippon Biomedical Laboratories was 7.23. The lowest was 1.22. And the median was 2.29.


Shin Nippon Biomedical Laboratories  (TSE:2395) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1279.00/676.11
=1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shin Nippon Biomedical Laboratories was 7.23. The lowest was 1.22. And the median was 2.29.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Related Terms


Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 394.68 457.67 523.12 604.39 676.11

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 604.39 620.87 637.84 663.52 676.11

TSE:2395 vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio falls into.


TSE:2395
74GF Score
Shin Nippon Biomedical Laboratories Ltd TSE:2395
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shin Nippon Biomedical Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1035.76/112.7000*112.7000
=1,035.760

Current CPI (Mar. 2026) = 112.7000.

Shin Nippon Biomedical Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 431.697 98.100 495.945
201609 494.137 98.000 568.258
201612 466.203 98.400 533.954
201703 539.279 98.100 619.539
201706 421.029 98.500 481.726
201709 422.766 98.800 482.244
201712 556.666 99.400 631.149
201803 628.331 99.200 713.840
201806 609.054 99.200 691.939
201809 788.229 99.900 889.223
201812 754.956 99.700 853.396
201903 682.384 99.700 771.361
201906 577.054 99.800 651.643
201909 504.052 100.100 567.499
201912 417.423 100.500 468.095
202003 391.239 100.300 439.608
202006 435.467 99.900 491.263
202009 349.914 99.900 394.748
202012 353.088 99.300 400.735
202103 377.941 99.900 426.366
202106 425.666 99.500 482.136
202109 430.973 100.100 485.221
202112 446.199 100.100 502.364
202203 469.857 101.100 523.767
202206 506.152 101.800 560.347
202209 597.849 103.100 653.517
202212 676.879 104.100 732.798
202303 629.608 104.400 679.663
202306 638.508 105.200 684.029
202309 759.934 106.200 806.446
202312 725.026 106.800 765.079
202403 819.428 107.200 861.470
202406 0.000 108.200 0.000
202409 875.030 108.900 905.564
202412 1,080.616 110.700 1,100.139
202503 961.345 111.100 975.190
202506 853.033 111.700 860.670
202509 909.739 112.000 915.425
202512 1,269.662 113.000 1,266.291
202603 1,035.760 112.700 1,035.760

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円676.11 mean?
Shin Nippon Biomedical Laboratories (TSE:2395) has a Cyclically Adjusted Book per Share of 円676.11 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' Cyclically Adjusted Book per Share too high?
Shin Nippon Biomedical Laboratories' current Cyclically Adjusted Book per Share is 円676.11. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Cyclically Adjusted Book per Share compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' Cyclically Adjusted Book per Share of 円676.11 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current Cyclically Adjusted Book per Share is 円676.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories (TSE:2395) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,783.15, compared to a current price of 円1,279.00 — trading 28.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円676.11. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (TSE:2395), the current Cyclically Adjusted Book per Share is 円676.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (TSE:2395) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of 円1,279.00 is trading 28.3% below its estimated GF Value™ of 円1,783.15. GuruFocus considers Shin Nippon Biomedical Laboratories to be Modestly Undervalued.

Key valuation signals for TSE:2395:

  • Cyclically Adjusted Book per Share: 円676.11
  • GF Value™: 円1,783.15 vs. price of 円1,279.00 (28.3% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the TSE:2395 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges YB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for TSE:2395

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,279.00
Price
円1,783.15
GF Value